Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer

European Journal of Surgical Oncology

Volumn 40, Issue 8, 2014, Pages 970-975

  Cascales Campos, P ^a   Gil, Jose ^a   Parrilla, Pascual ^a  

^a Carretera de Cartagena   (Spain)

Author keywords

Cytoreductive surgery; HIPEC; Morbidity; Ovarian cancer

Indexed keywords

CISPLATIN; INFUSION FLUID; METOCLOPRAMIDE; PACLITAXEL;

ABDOMINAL DISTENSION; ADULT; ADVANCED CANCER; AGED; ANAPHYLAXIS; ANASTOMOSIS LEAKAGE; ARTICLE; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CARCINOMATOSIS; COHORT ANALYSIS; COLORECTAL ANASTOMOSIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIARRHEA; FEMALE; HEMATOMA; HEMOPERITONEUM; HUMAN; HYDROTHORAX; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; INTESTINE RESECTION; INTRAVENOUS ADMINISTRATION; MAJOR CLINICAL STUDY; MORBIDITY; MULTIMODALITY CANCER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUTROPENIA; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; OVARIAN PERITONEAL CARCINOMATOSIS; OVARY CANCER; PARALYTIC ILEUS; PERITONEAL CANCER INDEX; PERITONEUM CANCER; PEROPERATIVE CARE; PLEURA EFFUSION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE NAUSEA; POSTOPERATIVE VOMITING; PRIMARY TUMOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REST; RETROSPECTIVE STUDY; SURGICAL INFECTION; SURGICAL MORTALITY; SYSTEMIC THERAPY; THROMBOCYTOPENIA; UPPER GASTROINTESTINAL BLEEDING; URINARY TRACT FISTULA;

CYTOREDUCTIVE SURGERY; HIPEC; MORBIDITY; OVARIAN CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; MORBIDITY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SPAIN;

EID: 84903899264     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.08.013     Document Type: Article

References (51)

1. M. Deraco, D. Baratti, and M.G. Inglese et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Ann Surg Oncol 11 2004 393 398
2. M. Deraco, P. Casali, and M.G. Inglese et al. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion J Surg Oncol 83 2003 147 153
3. V.J. Verwaal, S. Bruin, H. Boot, G. van Slooten, and H. van Tinteren 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol 15 9 2008 Sep 2426 2432
4. K.S. Ryu, J.H. Kim, and H.S. Ko et al. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer Gynecol Oncol 94 2004 325 332
5. T.C. Chua, G. Robertson, W. Liauw, R. Farrell, T.D. Yan, and D.L. Morris Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results J Cancer Res Clin Oncol 135 2009 1637 1645
6. www.clinicaltrials.gov. Last consult: 1-Dec-2012.
7. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
8. National Cancer Institute, Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v3.0 (CTCAE). Available at: http://ctep.cancer.gov/protocolDevelopment/electronic-applications/ctc.htm. [accessed June 10, 2013].
9. J.H. Kim, J.M. Lee, and K.S. Ryu et al. Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer J Surg Oncol 101 2010 149 155
10. P.A. Cascales Campos, J. Gil Martínez, and P.J. Galindo Fernández et al. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer Eur J Surg Oncol 37 2011 543 548
11. K. Chatzigeorgiou, S. Economou, and G. Chrysafis et al. Treatment of recurrent epithelial ovarian cancer with secondary cytoreduction and continuous intraoperative intraperitoneal hyperthermic chemoperfusion (CIIPHCP) Zentralbl Gynakol 125 2003 424 429
12. C. Zanon, R. Clara, and I. Chiappino et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer World J Surg 28 2004 1040 1045
13. P. Piso, M.H. Dahlke, M. Loss, and H.J. Schlitt Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer World J Surg Oncol 2 2004 21
14. F. Raspagliesi, S. Kusamura, and J.C. Campos Torres et al. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan Eur J Surg Oncol 32 2006 671 675
15. E. Cotte, O. Glehen, and F. Mohamed et al. Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients World J Surg 31 2007 1813 1820
16. J.H. Bae, J.M. Lee, and K.S. Ryu et al. Treatment of ovarian cancer with paclitaxel-or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery Gynecol Oncol 106 2007 193 200
17. A. Di Giorgio, E. Naticchioni, and D. Biacchi et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer Cancer 113 2008 315 325
18. E. Guardiola, D. Delroeux, and B. Heyd et al. Intra operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer World J Surg Oncol 9 2009 14
19. A. Fagotti, I. Paris, and F. Grimolizzi et al. Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study Gynecol Oncol 113 2009 335 340
20. J. Bereder, O. Glehen, and J. Habre et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from ovarian cancer: a multiinstitutional study of 246 patients J Clin Oncol 27 15s 2009 5542
21. M.J. Pavlov, P.A. Kovacevic, and M.S. Ceranic et al. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer - 12-year single center experience Eur J Surg Oncol 35 2009 1186 1191
22. M.C. Lim, S. Kang, and J. Choi et al. Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study Ann Surg Oncol 16 2009 993 1000
23. W.P. Ceelen, Y. Van Nieuwenhove, and S. Van Belle et al. Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer Ann Surg Oncol 2009 10.1245/s10434-009-0878-6
24. N. Carrabin, F. Mithieux, and P. Meeus et al. Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer Bull Cancer 97 2010 E23 E32
25. F. Roviello, E. Pinto, and G. Corso et al. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer J Surg Oncol 102 2010 663 670
26. C. Pomel, G. Ferron, and G. Lorimier et al. Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results: of a phase II prospective multicentre trial. CHIPOVAC study Eur J Surg Oncol 36 2010 589 593
27. J.S. Frenel, C. Leux, and L. Pouplin et al. Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: a pilot study of 31 patients J Surg Oncol 103 2011 10 16
28. M. Deraco, S. Kusamura, and S. Virzì et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial Gynecol Oncol 122 2011 215 220
29. A. Fagotti, B. Costantini, and G. Vizzielli et al. HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome Gynecol Oncol 122 2011 221 225
30. S. Rufian, F.C. Munoz-Casares, and J. Briceño et al. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer J Surg Oncol 94 2006 316 324
31. F.C. Muñoz-Casares, S. Rufián, and M.J. Rubio et al. The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer Clin Transl Oncol 11 2009 753 759
32. M. Deraco, C.R. Rossi, and E. Pennacchioli et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study Tumori 87 2001 120 126
33. T.D. Yan, M. Links, and S. Fransi et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy- a journey to becoming a Nationally Funded Peritonectomy Center Ann Surg Oncol 14 2007 2270 2280
34. S. Kusamura, R. Younan, and D. Baratti et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique Cancer 106 2006 1144 1153
35. A.D. Stephens, R. Alderman, and D. Chang et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique Ann Surg Oncol 6 1999 790 796
36. O. Glehen, D. Osinsky, and E. Cotte et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures Ann Surg Oncol 10 2003 863 869
37. T.D. Yan, G. Edwards, and R. Alderman et al. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma - a prospective study of 70 consecutive cases Ann Surg Oncol 14 2007 515 525
38. D. Elias, D. Goere, and F. Blot et al. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients Ann Surg Oncol 14 2007 1818 1824
39. R.M. Smeenk, V.J. Verwaal, and F.A. Zoetmulder Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei - a report of 103 procedures Eur J Surg Oncol 32 2006 186 190
40. V.J. Verwaal, H. van Tinteren, S.V. Ruth, and F.A. Zoetmulder Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy J Surg Oncol 85 2004 61 67
41. N. Gusani, S. Cho, and C. Colovos et al. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol 15 2008 754 763
42. P. Jacquet, A.D. Stephens, and A.M. Averbach et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy Cancer 77 1996 2622 2629
43. D. Elias, B. Raynard, and V. Boige et al. Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis J Surg Oncol 90 2005 220 225
44. C. Honore, R. Ciuchendea, and V. Billard et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Br J Surg 95 2008 1164 1171
45. U. Fumagalli, E. Trabucchi, and M. Soligo et al. Effects of intraperitoneal chemotherapy on anastomotic healing in rats J Surg Res 50 1991 82 87
46. V. Makrin, D. Lev-Chelouche, and E. Even Sapir et al. Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal study J Surg Oncol 89 2005 18 22
47. M. Kuzu, C. Koksoy, and T. Kale et al. Experimental study of the effect of preoperative 5-fluorouracil on the integrity of colonic anastomoses Br J Surg 85 1998 236 239
48. A.Y. Arikan, O. Gunal, M. Pehlivan, and M. Alper The effect of intraperitoneal paclitaxel administration on colonic anastomosis Hepatogastroenterology 47 2000 1273 1276
49. B.J. Moran, and T.D. Cecil The etiology, clinical presentation, and management of pseudomyxoma peritonei Surg Oncol Clin N Am 12 2003 585 603
50. J. Hansson, W. Graf, and L. Pahlman et al. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy Eur J Surg Oncol 35 2009 202 208
51. A. Chow, H.S. Tilney, and P. Paraskeva et al. The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6,107 cases Int J Colorectal Dis 24 2009 711 723